<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 30.2 - Macrocytic Anaemia (B12 and Folate Deficiency)</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 30.2 - Macrocytic Anaemia (B12 and Folate Deficiency) | MD3 SCP Cases">
  <meta name="description" content="A 72-year-old with progressive fatigue, paraesthesiae, and neurological signs of subacute combined degeneration. Learn about megaloblastic anaemia, B12 deficiency causes, and critical management principles.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:title" content="Case 30.2 - Macrocytic Anaemia (B12 and Folate Deficiency)">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="A 72-year-old with progressive fatigue, paraesthesiae, and neurological signs of subacute combined degeneration. Learn about megaloblastic anaemia, B12 deficiency causes, and critical management principles.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 30.2 – Macrocytic Anaemia (B12 and Folate Deficiency)</h1>
    <p class="meta"><strong>Category:</strong> Medicine | <strong>Discipline:</strong> Haematology | <strong>Setting:</strong> General Medical Clinic</p>

    <h2>Case</h2>
    <p>Mr. James Mitchell, a 72-year-old retired accountant, presents with a 6-month history of progressive fatigue, weakness, and "pins and needles" in both feet that have recently started affecting his hands. His wife has noticed he has become increasingly forgetful and irritable over the past few months. He describes difficulty with balance and has had two falls at home. He also reports a sore tongue and occasional diarrhea. His past medical history includes type 2 diabetes (managed with metformin 1g BD for 8 years) and a partial gastrectomy 15 years ago for a bleeding gastric ulcer. He denies alcohol excess. On examination, he appears pale with a lemon-yellow tinge to his skin. Neurological examination reveals loss of proprioception and vibration sense in both feet, absent ankle reflexes, and a positive Romberg's test. His tongue is smooth, red, and atrophic.</p>

    <div class="vital-signs">
      <strong>Vital signs:</strong> BP 128/78 mmHg, HR 88 bpm (regular), RR 14/min, Temp 36.9°C. <strong>Examination:</strong> Pale, mild jaundice (lemon-yellow tinge), smooth atrophic glossitis. <strong>Neurological:</strong> Reduced proprioception and vibration sense (posterior columns) in feet and hands, absent ankle jerks, positive Romberg's test. Upper motor neuron signs in legs (increased tone, upgoing plantars - suggesting subacute combined degeneration of the cord). Mild cognitive impairment on abbreviated mental test.
    </div>

    <h2>Investigations</h2>
    <div class="investigation-results">
      <strong>Full Blood Count:</strong>
      <ul>
        <li>Hb: 88 g/L (normal 130-180 g/L for men)</li>
        <li>MCV: 118 fL (normal 80-100 fL) - <strong>Macrocytic</strong></li>
        <li>WCC: 3.2 × 10⁹/L (normal 4-11) - mild leukopenia</li>
        <li>Neutrophils: 1.8 × 10⁹/L (hypersegmented on film)</li>
        <li>Platelets: 110 × 10⁹/L (normal 150-400) - mild thrombocytopenia</li>
        <li>Reticulocytes: 0.8% (normal 0.5-2.5%)</li>
      </ul>
      <strong>Blood film:</strong> Macrocytic red cells, hypersegmented neutrophils (\&gt;5 lobes), oval macrocytes.<br/>
      <strong>LDH:</strong> 850 U/L (normal 100-250) - elevated<br/>
      <strong>Bilirubin:</strong> 38 μmol/L (normal &lt;21) - unconjugated hyperbilirubinemia<br/>
      <strong>Haptoglobin:</strong> Low (ineffective erythropoiesis → intramedullary hemolysis)
    </div>

    <h2>Questions</h2>

    <div class="question">
      <button class="toggle-answer">1. Define macrocytic anaemia and outline the differential diagnosis. Distinguish between megaloblastic and non-megaloblastic causes.</button>
      <div class="answer">
        <p><strong>Definition of Macrocytic Anaemia:</strong></p>
        <p><strong>Macrocytic anaemia</strong> is defined as anaemia with an increased mean corpuscular volume (MCV >100 fL). The red blood cells are larger than normal.</p>

        <p><strong>Classification of Macrocytic Anaemia:</strong></p>

        <p><strong>1. MEGALOBLASTIC Anaemia (Impaired DNA Synthesis)</strong></p>

        <p><strong>Key Feature:</strong> Hypersegmented neutrophils on blood film (\&gt;5 lobes) - pathognomonic</p>

        <table>
          <tr>
            <th>Cause</th>
            <th>Mechanism</th>
            <th>Clinical Features</th>
          </tr>
          <tr>
            <td><strong>B12 Deficiency (most common)</strong></td>
            <td>B12 required for DNA synthesis (methionine synthase pathway). Deficiency → impaired cell division → large cells</td>
            <td>- <strong>Neurological features:</strong> Peripheral neuropathy, subacute combined degeneration, cognitive impairment<br/>
            - Glossitis, jaundice (↑ LDH from ineffective erythropoiesis)<br/>
            - Pancytopenia (affects all cell lines)</td>
          </tr>
          <tr>
            <td><strong>Folate Deficiency</strong></td>
            <td>Folate required for DNA synthesis (purine/pyrimidine synthesis). Deficiency → impaired cell division</td>
            <td>- <strong>NO neurological features</strong> (key difference from B12)<br/>
            - Glossitis, similar hematological picture to B12<br/>
            - Often dietary deficiency or malabsorption</td>
          </tr>
          <tr>
            <td><strong>Drugs</strong></td>
            <td>Interfere with DNA synthesis</td>
            <td>- <strong>Methotrexate</strong> (folate antagonist)<br/>
            - <strong>Hydroxyurea</strong> (chemotherapy)<br/>
            - Azathioprine, 6-mercaptopurine<br/>
            - Trimethoprim (folate antagonist)</td>
          </tr>
          <tr>
            <td><strong>Other</strong></td>
            <td>-</td>
            <td>- Myelodysplasia<br/>
            - Inherited disorders (orotic aciduria - rare)</td>
          </tr>
        </table>

        <p><strong>Causes of B12 Deficiency:</strong></p>
        <ul>
          <li><strong>Pernicious anaemia</strong> (autoimmune atrophic gastritis → loss of intrinsic factor) - most common in developed countries</li>
          <li><strong>Dietary deficiency:</strong> Vegans (B12 only in animal products), severe malnutrition</li>
          <li><strong>Malabsorption:</strong>
            <ul>
              <li>Post-gastrectomy (loss of intrinsic factor production in stomach)</li>
              <li>Terminal ileum disease (Crohn's, resection - B12 absorbed in terminal ileum)</li>
              <li>Pancreatic insufficiency (need pancreatic enzymes to release B12 from R-protein)</li>
              <li>Bacterial overgrowth, tapeworm (Diphyllobothrium latum)</li>
            </ul>
          </li>
          <li><strong>Drugs:</strong> Metformin (long-term use), PPIs, H2 blockers (reduce acid needed for B12 absorption)</li>
        </ul>

        <p><strong>Causes of Folate Deficiency:</strong></p>
        <ul>
          <li><strong>Dietary deficiency:</strong> Poor intake (alcoholics, elderly, poverty), overcooking vegetables (destroys folate)</li>
          <li><strong>Increased demand:</strong> Pregnancy, lactation, chronic hemolysis (sickle cell, hereditary spherocytosis), malignancy, chronic inflammatory states</li>
          <li><strong>Malabsorption:</strong> Coeliac disease, tropical sprue, Crohn's disease (jejunal disease)</li>
          <li><strong>Drugs:</strong> Methotrexate, trimethoprim, phenytoin, sulfasalazine</li>
        </ul>

        <p><strong>2. NON-MEGALOBLASTIC Anaemia</strong></p>

        <p><strong>Key Feature:</strong> Normal neutrophils (no hypersegmentation)</p>

        <table>
          <tr>
            <th>Cause</th>
            <th>Mechanism</th>
            <th>Key Features</th>
          </tr>
          <tr>
            <td><strong>Alcohol</strong></td>
            <td>Direct toxic effect on bone marrow → large RBCs</td>
            <td>- MCV often 100-110 fL (moderate ↑)<br/>
            - May have thrombocytopenia, liver disease<br/>
            - Reverses with abstinence</td>
          </tr>
          <tr>
            <td><strong>Liver disease</strong></td>
            <td>Altered lipid metabolism → increased RBC membrane lipid</td>
            <td>- Target cells on film<br/>
            - Deranged LFTs, stigmata of chronic liver disease</td>
          </tr>
          <tr>
            <td><strong>Hypothyroidism</strong></td>
            <td>Reduced metabolism → slow RBC production</td>
            <td>- Usually mild macrocytosis<br/>
            - ↑ TSH, ↓ T4<br/>
            - Symptoms: fatigue, weight gain, cold intolerance</td>
          </tr>
          <tr>
            <td><strong>Reticulocytosis</strong></td>
            <td>Reticulocytes are larger than mature RBCs</td>
            <td>- Hemolysis, acute blood loss (compensatory response)<br/>
            - Elevated reticulocyte count (\&gt;2%)</td>
          </tr>
          <tr>
            <td><strong>Myelodysplastic syndrome (MDS)</strong></td>
            <td>Dysplastic bone marrow → abnormal RBC production</td>
            <td>- Elderly patients<br/>
            - Cytopenia (one or more cell lines)<br/>
            - Bone marrow biopsy diagnostic</td>
          </tr>
          <tr>
            <td><strong>Aplastic anaemia</strong></td>
            <td>Bone marrow failure → macrocytic cells (stress erythropoiesis)</td>
            <td>- Pancytopenia<br/>
            - Hypocellular bone marrow</td>
          </tr>
          <tr>
            <td><strong>Drugs</strong></td>
            <td>Various mechanisms</td>
            <td>- Azathioprine, hydroxyurea (also megaloblastic)<br/>
            - Zidovudine (AZT)</td>
          </tr>
        </table>

        <p><strong>Distinguishing Megaloblastic vs Non-Megaloblastic:</strong></p>
        <table>
          <tr>
            <th>Feature</th>
            <th>Megaloblastic</th>
            <th>Non-Megaloblastic</th>
          </tr>
          <tr>
            <td><strong>Hypersegmented neutrophils</strong></td>
            <td><strong>PRESENT</strong> (\&gt;5 lobes)</td>
            <td>Absent</td>
          </tr>
          <tr>
            <td><strong>MCV</strong></td>
            <td>Usually >110 fL (markedly elevated)</td>
            <td>100-110 fL (mild-moderate elevation)</td>
          </tr>
          <tr>
            <td><strong>Pancytopenia</strong></td>
            <td>Common (B12/folate deficiency affects all cell lines)</td>
            <td>Less common (unless bone marrow failure)</td>
          </tr>
          <tr>
            <td><strong>LDH</strong></td>
            <td>Markedly elevated (ineffective erythropoiesis)</td>
            <td>Normal or mildly elevated</td>
          </tr>
          <tr>
            <td><strong>Bilirubin</strong></td>
            <td>Mildly elevated (unconjugated - intramedullary hemolysis)</td>
            <td>Normal</td>
          </tr>
        </table>

        <p><strong>Mr. Mitchell's Case:</strong></p>
        <p>Features strongly suggesting <strong>Megaloblastic Anaemia due to B12 Deficiency:</strong></p>
        <ul>
          <li>Macrocytic anaemia (MCV 118 fL - markedly elevated)</li>
          <li>Hypersegmented neutrophils (megaloblastic)</li>
          <li>Pancytopenia (Hb 88, WCC 3.2, platelets 110)</li>
          <li>Elevated LDH (850) + unconjugated bilirubin (38) - ineffective erythropoiesis</li>
          <li><strong>Neurological signs:</strong> Peripheral neuropathy, posterior column signs, cognitive impairment (specific to B12, NOT folate)</li>
          <li><strong>Risk factors:</strong> Previous gastrectomy (loss of intrinsic factor), long-term metformin use (impairs B12 absorption)</li>
        </ul>

        <p><strong>Next step:</strong> Check B12 and folate levels, intrinsic factor antibodies, parietal cell antibodies</p>
      </div>
    </div>

    <div class="question">
      <button class="toggle-answer">2. Describe the clinical features of B12 deficiency, particularly the neurological manifestations. How does subacute combined degeneration of the spinal cord occur and what are its key features?</button>
      <div class="answer">
        <p><strong>Clinical Features of B12 Deficiency:</strong></p>

        <p><strong>1. Haematological Features:</strong></p>
        <ul>
          <li><strong>Anaemia:</strong> Insidious onset, symptoms of fatigue, dyspnea, pallor</li>
          <li><strong>Pancytopenia:</strong> Can affect all cell lines
            <ul>
              <li>Leukopenia → increased infection risk</li>
              <li>Thrombocytopenia → bruising, bleeding (usually mild)</li>
            </ul>
          </li>
          <li><strong>Mild jaundice:</strong> Lemon-yellow tinge (combination of pallor + unconjugated hyperbilirubinemia from ineffective erythropoiesis)</li>
        </ul>

        <p><strong>2. Gastrointestinal Features:</strong></p>
        <ul>
          <li><strong>Glossitis:</strong> Sore, smooth, red, "beefy" tongue (atrophy of papillae)</li>
          <li>Angular stomatitis (cracks at corners of mouth)</li>
          <li>Diarrhea, weight loss (malabsorption if underlying GI pathology)</li>
        </ul>

        <p><strong>3. Neurological Features (Unique to B12 - NOT seen in folate deficiency):</strong></p>

        <p><strong>Neurological complications occur in ~75% of B12-deficient patients and can occur BEFORE anaemia develops.</strong></p>

        <p><strong>A. Peripheral Neuropathy:</strong></p>
        <ul>
          <li><strong>Symmetrical sensory neuropathy</strong> (most common neurological manifestation)</li>
          <li>"Glove and stocking" distribution - starts in feet, ascends to hands</li>
          <li>Symptoms: Paraesthesiae ("pins and needles"), numbness, pain</li>
          <li>Loss of ankle reflexes</li>
        </ul>

        <p><strong>B. Subacute Combined Degeneration of the Spinal Cord (SACD):</strong></p>

        <p><strong>Pathophysiology:</strong></p>
        <ul>
          <li>B12 deficiency → impaired methylation reactions → <strong>defective myelin synthesis</strong></li>
          <li>Progressive demyelination of:
            <ul>
              <li><strong>Posterior columns</strong> (dorsal columns - carry proprioception and vibration)</li>
              <li><strong>Lateral corticospinal tracts</strong> (carry motor signals)</li>
              <li><strong>Spinocerebellar tracts</strong></li>
            </ul>
          </li>
          <li>If untreated → <strong>irreversible axonal loss</strong> (critical to treat early)</li>
        </ul>

        <p><strong>Clinical Features of SACD:</strong></p>

        <table>
          <tr>
            <th>Tract Affected</th>
            <th>Clinical Signs</th>
            <th>Symptoms</th>
          </tr>
          <tr>
            <td><strong>Posterior (Dorsal) Columns</strong></td>
            <td>- Loss of vibration sense (test with tuning fork)<br/>
            - Loss of proprioception (joint position sense)<br/>
            - Positive Romberg's test (stands stable with eyes open, falls when eyes closed - relies on vision to compensate for lost proprioception)<br/>
            - Sensory ataxia (wide-based gait)</td>
            <td>- Unsteadiness, difficulty walking in dark<br/>
            - Feels like "walking on cotton wool"<br/>
            - Frequent falls</td>
          </tr>
          <tr>
            <td><strong>Lateral Corticospinal Tracts (Pyramidal)</strong></td>
            <td>- Upper motor neuron signs:<br/>
            &nbsp;&nbsp;• Increased tone (spasticity) in legs<br/>
            &nbsp;&nbsp;• Brisk knee reflexes<br/>
            &nbsp;&nbsp;• Extensor plantar responses (Babinski +)<br/>
            &nbsp;&nbsp;• Weakness (legs > arms)</td>
            <td>- Leg stiffness<br/>
            - Weakness, difficulty climbing stairs</td>
          </tr>
          <tr>
            <td><strong>Spinocerebellar Tracts</strong></td>
            <td>- Ataxia<br/>
            - Intention tremor</td>
            <td>- Incoordination<br/>
            - Difficulty with fine motor tasks</td>
          </tr>
        </table>

        <p><strong>Classic Presentation of SACD:</strong></p>
        <ul>
          <li><strong>Combination of UMN and LMN signs:</strong>
            <ul>
              <li><strong>UMN:</strong> Spasticity, brisk reflexes, upgoing plantars (corticospinal tract)</li>
              <li><strong>LMN:</strong> Absent ankle jerks (peripheral neuropathy)</li>
            </ul>
          </li>
          <li>This combination is <strong>unusual</strong> and should prompt consideration of B12 deficiency</li>
        </ul>

        <p><strong>C. Cognitive and Psychiatric Features:</strong></p>
        <ul>
          <li><strong>Cognitive impairment:</strong> Memory loss, confusion, dementia-like picture</li>
          <li><strong>Psychiatric:</strong> Depression, irritability, psychosis, personality change</li>
          <li>"Megaloblastic madness" - historical term for severe B12 deficiency with psychosis</li>
        </ul>

        <p><strong>D. Optic Neuropathy (Rare):</strong></p>
        <ul>
          <li>Visual impairment, optic atrophy</li>
        </ul>

        <p><strong>4. Other Features:</strong></p>
        <ul>
          <li>Infertility (both sexes)</li>
          <li>Hyperpigmentation (especially in dark-skinned individuals)</li>
        </ul>

        <p><strong>Differential Diagnosis of SACD:</strong></p>
        <table>
          <tr>
            <th>Condition</th>
            <th>Key Differentiating Features</th>
          </tr>
          <tr>
            <td><strong>Multiple sclerosis</strong></td>
            <td>- Younger age (20-40s)<br/>
            - Relapsing-remitting course<br/>
            - MRI: demyelinating plaques<br/>
            - Normal B12</td>
          </tr>
          <tr>
            <td><strong>Tabes dorsalis (neurosyphilis)</strong></td>
            <td>- Posterior column involvement only (not corticospinal)<br/>
            - Argyll-Robertson pupils, lightning pains<br/>
            - Positive syphilis serology</td>
          </tr>
          <tr>
            <td><strong>Copper deficiency</strong></td>
            <td>- Very similar to SACD (posterior columns + corticospinal)<br/>
            - History: gastric bypass, excessive zinc supplementation<br/>
            - Low serum copper/caeruloplasmin</td>
          </tr>
          <tr>
            <td><strong>HIV myelopathy</strong></td>
            <td>- Known HIV infection<br/>
            - Vacuolar myelopathy<br/>
            - CD4 &lt;200</td>
          </tr>
        </table>

        <p><strong>Timing and Reversibility of Neurological Damage:</strong></p>
        <table>
          <tr>
            <th>Duration of Deficiency</th>
            <th>Reversibility with Treatment</th>
          </tr>
          <tr>
            <td><strong>&lt;6 months</strong></td>
            <td><strong>Usually fully reversible</strong> if treated promptly</td>
          </tr>
          <tr>
            <td><strong>6-12 months</strong></td>
            <td>Partial recovery; some residual deficits may remain</td>
          </tr>
          <tr>
            <td><strong>>12 months</strong></td>
            <td><strong>Largely irreversible</strong> - axonal loss and permanent damage</td>
          </tr>
        </table>

        <p><strong>Critical Clinical Point:</strong></p>
        <p><strong>Neurological symptoms can occur with NORMAL or near-normal haemoglobin</strong> - up to 25% of patients with B12 neuropathy have Hb >100 g/L. Therefore:</p>
        <ul>
          <li>Cannot rely on anaemia to exclude B12 deficiency</li>
          <li>Check B12 in ANY patient with unexplained neuropathy, cognitive impairment, or psychiatric symptoms</li>
          <li><strong>NEVER give folic acid without checking B12 first</strong> - folic acid can correct the anaemia but worsen neurological damage</li>
        </ul>

        <p><strong>Mr. Mitchell's Neurological Features:</strong></p>
        <table>
          <tr>
            <th>Finding</th>
            <th>Localisation</th>
          </tr>
          <tr>
            <td>Paraesthesiae in feet and hands</td>
            <td>Peripheral neuropathy</td>
          </tr>
          <tr>
            <td>Loss of proprioception and vibration sense</td>
            <td><strong>Posterior columns</strong></td>
          </tr>
          <tr>
            <td>Positive Romberg's test</td>
            <td>Posterior column dysfunction</td>
          </tr>
          <tr>
            <td>Absent ankle reflexes</td>
            <td>Peripheral neuropathy (LMN)</td>
          </tr>
          <tr>
            <td>Increased tone, upgoing plantars</td>
            <td><strong>Lateral corticospinal tracts</strong> (UMN)</td>
          </tr>
          <tr>
            <td>Falls, ataxia</td>
            <td>Posterior columns + spinocerebellar tracts</td>
          </tr>
          <tr>
            <td>Cognitive impairment, irritability</td>
            <td>Cerebral involvement</td>
          </tr>
        </table>

        <p><strong>Diagnosis:</strong> <strong>Subacute combined degeneration of the spinal cord</strong> due to B12 deficiency</p>

        <p><strong>Urgent Action Required:</strong> Start B12 replacement IMMEDIATELY - delay can lead to permanent neurological damage</p>
      </div>
    </div>

    <div class="question">
      <button class="toggle-answer">3. Outline the investigation and management of B12 and folate deficiency. Why should folate NEVER be given without checking B12 first?</button>
      <div class="answer">
        <p><strong>Investigation of Suspected B12/Folate Deficiency:</strong></p>

        <p><strong>Step 1: Confirm Deficiency</strong></p>

        <table>
          <tr>
            <th>Test</th>
            <th>Interpretation</th>
            <th>Notes</th>
          </tr>
          <tr>
            <td><strong>Serum B12</strong></td>
            <td>- <strong>&lt;148 pmol/L:</strong> Deficient<br/>
            - 148-250 pmol/L: Borderline/grey zone<br/>
            - >250 pmol/L: Normal</td>
            <td>- False low: Pregnancy, TCII deficiency, folate deficiency<br/>
            - False normal: Myeloproliferative disorders, liver disease<br/>
            - If borderline + clinical suspicion → check MMA/homocysteine</td>
          </tr>
          <tr>
            <td><strong>Serum Folate</strong></td>
            <td>- &lt;7 nmol/L: Deficient<br/>
            - >7 nmol/L: Normal</td>
            <td>- Red cell folate more accurate (reflects tissue stores) but less commonly done<br/>
            - Can fluctuate with recent dietary intake</td>
          </tr>
          <tr>
            <td><strong>Methylmalonic acid (MMA)</strong></td>
            <td>↑ Elevated in B12 deficiency<br/>
            (B12 needed to convert MMA → succinyl-CoA)</td>
            <td>- More sensitive than serum B12<br/>
            - Use when B12 borderline but high clinical suspicion<br/>
            - Also elevated in renal failure</td>
          </tr>
          <tr>
            <td><strong>Homocysteine</strong></td>
            <td>↑ Elevated in B12 OR folate deficiency<br/>
            (Both needed for homocysteine → methionine)</td>
            <td>- Less specific (elevated in both B12 and folate deficiency)<br/>
            - Also elevated in CKD, hypothyroidism, some drugs</td>
          </tr>
        </table>

        <p><strong>Step 2: Identify the Cause of B12 Deficiency</strong></p>

        <table>
          <tr>
            <th>Test</th>
            <th>Indication</th>
            <th>Result</th>
          </tr>
          <tr>
            <td><strong>Intrinsic Factor (IF) Antibodies</strong></td>
            <td>Suspected pernicious anaemia</td>
            <td>- Positive in ~50% of pernicious anaemia cases<br/>
            - <strong>High specificity</strong> (~95%) - if positive, confirms pernicious anaemia<br/>
            - Negative does NOT exclude pernicious anaemia</td>
          </tr>
          <tr>
            <td><strong>Parietal Cell Antibodies (PCA)</strong></td>
            <td>Suspected pernicious anaemia</td>
            <td>- Positive in ~90% of pernicious anaemia<br/>
            - Low specificity (also positive in 10% of normal population)<br/>
            - Less useful than IF antibodies</td>
          </tr>
          <tr>
            <td><strong>Gastroscopy (OGD)</strong></td>
            <td>- Exclude gastric pathology<br/>
            - Confirm atrophic gastritis</td>
            <td>- Pernicious anaemia: atrophic gastritis, loss of rugae<br/>
            - Biopsies: intestinal metaplasia, absence of parietal cells<br/>
            - Also screens for gastric cancer (↑ risk in pernicious anaemia)</td>
          </tr>
          <tr>
            <td><strong>Anti-TTG antibodies</strong></td>
            <td>Suspected coeliac disease</td>
            <td>Screen if malabsorption suspected</td>
          </tr>
        </table>

        <p><strong>Step 3: Identify Cause of Folate Deficiency</strong></p>

        <ul>
          <li><strong>Dietary history:</strong> Assess intake, alcohol use</li>
          <li><strong>Drug history:</strong> Methotrexate, trimethoprim, phenytoin, sulfasalazine</li>
          <li><strong>Malabsorption screen:</strong> Coeliac serology, consider OGD with duodenal biopsies</li>
          <li><strong>Assess for increased demand:</strong> Pregnancy, hemolysis (check reticulocyte count, bilirubin, LDH, haptoglobin)</li>
        </ul>

        <p><strong>Management of B12 Deficiency:</strong></p>

        <p><strong>1. B12 Replacement - Route Depends on Cause:</strong></p>

        <p><strong>A. Intramuscular (IM) B12 - Hydroxocobalamin:</strong></p>

        <p><strong>Indications:</strong></p>
        <ul>
          <li>Pernicious anaemia (no intrinsic factor → cannot absorb oral B12)</li>
          <li>Post-gastrectomy</li>
          <li>Terminal ileal disease/resection</li>
          <li>Any malabsorption causing B12 deficiency</li>
          <li>Neurological involvement (to ensure rapid repletion)</li>
        </ul>

        <p><strong>Dosing Regimen:</strong></p>
        <table>
          <tr>
            <th>Clinical Scenario</th>
            <th>Loading Dose</th>
            <th>Maintenance</th>
          </tr>
          <tr>
            <td><strong>B12 deficiency WITHOUT neurological symptoms</strong></td>
            <td><strong>1 mg IM 3 times per week</strong> for 2 weeks<br/>
            (6 doses total)</td>
            <td><strong>1 mg IM every 3 months</strong> for life</td>
          </tr>
          <tr>
            <td><strong>B12 deficiency WITH neurological symptoms</strong></td>
            <td><strong>1 mg IM on alternate days</strong> until no further improvement<br/>
            (usually ~2-3 months; minimum 6 doses)</td>
            <td><strong>1 mg IM every 2 months</strong> for life</td>
          </tr>
        </table>

        <p><strong>B. Oral B12 (Cyanocobalamin or Hydroxocobalamin):</strong></p>

        <p><strong>Indications:</strong></p>
        <ul>
          <li>Dietary deficiency (vegans) - intact GI tract</li>
          <li>Patient preference (if no malabsorption and no neurological involvement)</li>
        </ul>

        <p><strong>Dose:</strong> 50-1000 mcg daily (high-dose oral B12 can overcome malabsorption via passive diffusion)</p>

        <p><strong>Note:</strong> IM is strongly preferred for pernicious anaemia and neurological involvement</p>

        <p><strong>2. Management of Folate Deficiency:</strong></p>

        <p><strong>Folic Acid Supplementation:</strong></p>
        <ul>
          <li><strong>Dose:</strong> 5 mg oral daily</li>
          <li><strong>Duration:</strong>
            <ul>
              <li>4 months for dietary deficiency (to replenish stores)</li>
              <li>Lifelong if ongoing cause (e.g., hemolysis, malabsorption)</li>
            </ul>
          </li>
        </ul>

        <p><strong>Prophylactic Folic Acid:</strong></p>
        <ul>
          <li><strong>Pregnancy:</strong> 400 mcg daily (prevents neural tube defects)</li>
          <li><strong>Chronic hemolysis:</strong> 5 mg daily (e.g., sickle cell disease, hereditary spherocytosis)</li>
          <li><strong>Methotrexate therapy:</strong> 5 mg weekly (day after methotrexate dose)</li>
        </ul>

        <p><strong>3. Treat Underlying Cause:</strong></p>
        <ul>
          <li>Dietary advice (increase folate-rich foods: green vegetables, fortified cereals)</li>
          <li>Treat coeliac disease (gluten-free diet)</li>
          <li>Stop causative drugs if possible (e.g., methotrexate)</li>
          <li>Alcohol cessation counseling</li>
        </ul>

        <p><strong>CRITICAL PRINCIPLE: NEVER Give Folate Without Checking B12 First</strong></p>

        <p><strong>Why?</strong></p>

        <p><strong>1. Masking of B12 Deficiency:</strong></p>
        <ul>
          <li>Folate can <strong>partially correct the megaloblastic anaemia</strong> caused by B12 deficiency</li>
          <li>Hb improves, MCV normalizes → falsely reassuring</li>
          <li>Underlying B12 deficiency remains <strong>undiagnosed and untreated</strong></li>
        </ul>

        <p><strong>2. Precipitation/Worsening of Neurological Damage:</strong></p>
        <ul>
          <li><strong>Folate does NOT correct B12-related neurological problems</strong></li>
          <li>In fact, giving folate may <strong>worsen or precipitate subacute combined degeneration</strong></li>
          <li>Mechanism unclear but possibly related to:
            <ul>
              <li>Increased methylation demand (depletes limited B12 stores)</li>
              <li>Worsening of methylmalonic acidemia</li>
            </ul>
          </li>
          <li><strong>Result:</strong> Patient's anaemia improves but develops irreversible neurological damage</li>
        </ul>

        <p><strong>Clinical Scenario Illustrating the Danger:</strong></p>
        <p>Patient with B12 deficiency (undiagnosed) + macrocytic anaemia → given folic acid → Hb improves → B12 deficiency not suspected → patient develops progressive, irreversible SACD</p>

        <p><strong>Safe Practice:</strong></p>
        <ol>
          <li><strong>ALWAYS check both B12 AND folate</strong> in macrocytic anaemia</li>
          <li>If B12 deficient → treat B12 FIRST</li>
          <li>If both B12 and folate deficient → treat BOTH (B12 + folic acid together)</li>
          <li>If only folate deficient → safe to give folic acid alone</li>
        </ol>

        <p><strong>4. Monitoring Response to Treatment:</strong></p>

        <p><strong>Expected Response:</strong></p>
        <table>
          <tr>
            <th>Timeframe</th>
            <th>Expected Change</th>
          </tr>
          <tr>
            <td><strong>24-48 hours</strong></td>
            <td>- Subjective improvement (patient feels better)<br/>
            - Reticulocytosis (peak at 5-7 days) - indicates marrow responding</td>
          </tr>
          <tr>
            <td><strong>1-2 weeks</strong></td>
            <td>- Hb starts to rise (10-20 g/L per week)<br/>
            - Hypersegmented neutrophils disappear</td>
          </tr>
          <tr>
            <td><strong>6-8 weeks</strong></td>
            <td>- Hb normalizes<br/>
            - MCV normalizes</td>
          </tr>
          <tr>
            <td><strong>3-6 months</strong></td>
            <td>- Neurological improvement (if present)<br/>
            - Peripheral neuropathy improves first<br/>
            - Posterior column signs may take longer or be permanent if long-standing</td>
          </tr>
        </table>

        <p><strong>Monitoring Tests:</strong></p>
        <ul>
          <li>FBC at 1-2 weeks, then 8 weeks</li>
          <li>No need to recheck B12/folate levels during treatment (will be falsely elevated)</li>
          <li>Assess neurological status regularly if SACD present</li>
        </ul>

        <p><strong>5. Long-term Considerations:</strong></p>

        <p><strong>Pernicious Anaemia:</strong></p>
        <ul>
          <li><strong>Lifelong B12 injections</strong> (every 2-3 months)</li>
          <li><strong>Increased risk of gastric cancer</strong> (3-fold) → OGD surveillance not routinely recommended but maintain high index of suspicion for alarm symptoms</li>
          <li><strong>Increased risk of other autoimmune diseases:</strong> Thyroid disease, vitiligo, Addison's disease</li>
        </ul>

        <p><strong>Management Plan for Mr. Mitchell:</strong></p>
        <ol>
          <li><strong>Check B12 and folate levels</strong> (before starting treatment if possible, but don't delay if severe)</li>
          <li><strong>Start IM hydroxocobalamin URGENTLY:</strong>
            <ul>
              <li>1 mg IM on alternate days (has neurological involvement)</li>
              <li>Continue until no further neurological improvement (likely 2-3 months)</li>
              <li>Then 1 mg IM every 2 months for life</li>
            </ul>
          </li>
          <li><strong>Investigations to find cause:</strong>
            <ul>
              <li>Intrinsic factor antibodies (likely positive - has previous gastrectomy)</li>
              <li>Consider OGD (though history of gastrectomy already explains B12 deficiency)</li>
            </ul>
          </li>
          <li><strong>Monitor response:</strong>
            <ul>
              <li>FBC in 1-2 weeks (expect reticulocytosis, rising Hb)</li>
              <li>Reassess neurological status monthly</li>
            </ul>
          </li>
          <li><strong>Patient education:</strong>
            <ul>
              <li>Lifelong B12 injections required</li>
              <li>Neurological improvement may take months; some deficits may be permanent</li>
            </ul>
          </li>
          <li><strong>Review metformin:</strong> Consider alternative diabetes medication (though B12 deficiency likely due to gastrectomy, metformin may contribute)</li>
        </ol>
      </div>
    </div>

  </div>

  <!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        }
      }
    // Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          }
        }, 100);
      }
    });
    }
  </script>

  </div>

  <!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        }
      }
    }</script>

</body>
</html>
